NCT00669097View on ClinicalTrials.gov

Absorption, Distribution, Metabolism and Excretion (ADME) Study of TKI258 in Patients With Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

January 31, 2010

Conditions
Advanced Solid Malignancies
Interventions
DRUG

TKI258

Trial Locations (1)

Unknown

Novartis Investigative Site, Amsterdam

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY